27 results
8-K
EX-3.1
QLGN
Qualigen Therapeutics Inc
22 Nov 22
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
9:10am
10-Q
2021 Q2
EX-3.8
QLGN
Qualigen Therapeutics Inc
Quarterly report
16 Aug 21
4:16pm
8-K
EX-3.1
QLGN
Qualigen Therapeutics Inc
13 Aug 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-3.1
QLGN
Qualigen Therapeutics Inc
17 May 21
Amendments to Articles of Incorporation or Bylaws
5:21pm
8-K
EX-3.1
QLGN
Qualigen Therapeutics Inc
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-3.2
m2sx3bce5io5p4d d62
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-3.6
7xofy yxko
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-3.4
asdy qglc5m0
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-3.3
zvm0s5c7
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-3.5
gghxkhhb
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
S-4/A
EX-3.8
noy07mew vdhi
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
8-K
EX-3.1
gbc 7krkke8xovf
22 Mar 18
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-3.1
6g4ay
4 Oct 17
Ritter Pharmaceuticals, Inc. Prices $23,000,000 Public Offering
12:00am
8-K
EX-3.1
cxucdfx8 7p
15 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
kv20lkm5b5bi0a
1 Jul 15
Departure of Directors or Certain Officers
12:00am